These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 30962331)

  • 21.
    Chew KL; Octavia S; Yeoh SF; Teo JWP
    Microbiol Spectr; 2021 Sep; 9(1):e0004521. PubMed ID: 34132613
    [No Abstract]   [Full Text] [Related]  

  • 22. Omadacycline for management of Mycobacterium abscessus infections: a review of its effectiveness, place in therapy, and considerations for use.
    Rizzo AR; Moniri NH
    BMC Infect Dis; 2022 Nov; 22(1):874. PubMed ID: 36419143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanisms.
    Mendes RE; Huband MD; Streit JM; Castanheira M; Flamm RK
    Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115054. PubMed ID: 32376058
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Fujiwara K; Aono A; Asami T; Morimoto K; Kamada K; Morishige Y; Igarashi Y; Chikamatsu K; Murase Y; Yamada H; Takaki A; Mitarai S
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0157922. PubMed ID: 37154742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omadacycline in first-line combination therapy for pulmonary Mycobacterium abscessus infection: a case series.
    Duah M; Beshay M
    Int J Infect Dis; 2022 Sep; 122():953-956. PubMed ID: 35798234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay.
    Portell-Buj E; Bonet-Rossinyol Q; López-Gavín A; Roman A; Fernández-Pittol M; Tudó G; Gonzalez-Martin J
    J Antibiot (Tokyo); 2021 Apr; 74(4):285-290. PubMed ID: 33420382
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Shen Y; Wang X; Jin J; Wu J; Zhang X; Chen J; Zhang W
    Biomed Res Int; 2018; 2018():4902941. PubMed ID: 30687747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omadacycline drug susceptibility testing for non-tuberculous mycobacteria using oxyrase to overcome challenges with drug degradation.
    Boorgula GD; Gumbo T; Singh S; McShane PJ; Philley JV; Srivastava S
    Tuberculosis (Edinb); 2024 Jul; 147():102519. PubMed ID: 38754247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach.
    Liu Y; Tan Y; Islam MM; Cao Y; Lu X; Zeng S; Hameed HMA; Zhou P; Cai X; Wang S; Mugweru JN; Zhang G; Yin H; Liu J; Nuermberger E; Zhang T
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31843996
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro antimicrobial activity of doxycycline, minocycline, and tigecycline against Mycobacterium abscessus complex: A meta-analysis study.
    Zhang W; Dong L; Men P; Jiang G; Wang F; Wang C; Cheng M; Huang H; Yu X
    Diagn Microbiol Infect Dis; 2024 Oct; 110(2):116435. PubMed ID: 39032320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.
    Viljoen A; Raynaud C; Johansen MD; Roquet-Banères F; Herrmann JL; Daher W; Kremer L
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics and antimicrobial susceptibility profiles of Mycobacterium abscessus and Mycobacterium massiliense pulmonary infection.
    Guo W; Shangguan Y; Ji Z; Hu M; Li X; Hu W; Zheng L; Huang S; Wang Y; Xia J; Jiang L; Xu K
    J Glob Antimicrob Resist; 2024 Sep; 38():83-89. PubMed ID: 38719186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the
    Pryjma M; Burian J; Kuchinski K; Thompson CJ
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child.
    Myojin S; Fukuoka K; Kanemaru A; Baba S; Okamoto Y; Suzuki H; Kamada K; Yoshida A; Kikuchi K; Horikoshi Y
    Int J Infect Dis; 2018 Sep; 74():10-12. PubMed ID: 29966711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Correlation of Antibiotic Susceptibility and Resistance Genotyping for the
    Zheng H; Liu D; Lu J; Song Y; Wang S; Zhao Y; Ni X
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro susceptibility of Mycobacterium abscessus complex and feasibility of standardizing treatment regimens.
    Chew KL; Octavia S; Go J; Ng S; Tang YE; Soh P; Yong J; Jureen R; Lin RTP; Yeoh SF; Teo J
    J Antimicrob Chemother; 2021 Mar; 76(4):973-978. PubMed ID: 33338230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thiostrepton: A Novel Therapeutic Drug Candidate for
    Kim TH; Hanh BTB; Kim G; Lee DG; Park JW; Lee SE; Kim JS; Kim BS; Ryoo S; Jo EK; Jang J
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31835481
    [No Abstract]   [Full Text] [Related]  

  • 39. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
    Wallace RJ; Brown-Elliott BA; Crist CJ; Mann L; Wilson RW
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3164-7. PubMed ID: 12234839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.